Dysregulated Expression of miR-222 and miR-15a in Transfusion-Dependent Thalassemia: Associations with Torque Teno Virus and Cytomegalovirus Infections

  • Mahdiyar Iravani Saadi Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Nasrin Noshadi Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Fakhroddin Hosseini Hematology, Oncology, and Bone Marrow Transplantation Department, Shiraz University of Medical Sciences, Shiraz, Iran
  • Soodabeh Zare Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Ramin Yaghobi Shiraz Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Zahed Karimi Hematology, Oncology, and Bone Marrow Transplantation Department, Shiraz University of Medical Sciences, Shiraz, Iran
  • Zahra Ghahramani Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Mani Ramzi Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Keywords: Transfusion-dependent beta-thalassemia; MicroRNA; Expression levels; Viral infection prevalence; miRNA

Abstract

Background: Beta-thalassemia is a hereditary blood disorder characterized by reduced synthesis of the beta-globin chain. MicroRNAs (miRs) are small RNA molecules that regulate gene expression and have been implicated in beta-thalassemia. To explore dysregulated miR-222 and miR-15a expression in transfusion-dependent beta-thalassemia and assess their potential associations with Torque Teno Virus and cytomegalovirus infections.

Materials and Methods: This study included 57 TDT patients registered at the Thalassemia Clinic affiliated with the Hematology Research Center, Shiraz, Iran. The expression levels of miR-222 and miR-15a were analyzed using the real-time SYBR Green PCR method. TTV and CMV infections were detected by analyzing the presence of their genomic DNA using an in-house semi-nested PCR protocol.

Results: The expression level of miR-222 was significantly up-regulated (47.5-fold, P≤0.001) in TDT patients compared to healthy controls. However, the expression of miR-15a in TDT patients was slightly decreased compared to healthy controls, but the difference was not statistically significant (P=0.193). TTV infection was observed in 21.1% of TDT patients, while CMV infection was detected in 5.2% of the patients. Although miR-222 and miR-15a gene expression levels were higher in TTV-positive patients compared to TTV-negative patients, the differences were not statistically significant (P=0.926 and P=0.243, respectively).

Conclusion: MiR-222 was up-regulated in TDT patients, but miR-15a did not show a significant difference. TTV and CMV infections were detected, but their association with miR expression was not significant, possibly due to the small sample size. Larger studies are needed for a more comprehensive evaluation.

Published
2025-10-20
Section
Articles